Adyen: A 20% Compounder Is Finally Cheap Enough
Adyen: A 20% Compounder Is Finally Cheap Enough
Adyen: A 20% Compounder Is Finally Cheap Enough
Follow AbCellera Biologics Inc. (ABCL) Q2 2026 Earnings Call August 5, 2026 5:00 PM EDT Company Participants Tryn Stimart – Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy OfficerCarl L. Hansen – CEO, President & ChairpersonAndrew Booth – Chief Financial Officer Conference Call Participants Steven Seedhouse – Cantor Fitzgerald & Co., Research DivisionSrikripa…
Andy Burnham could hardly have chosen a more appropriate housing priority for his first days as Prime Minister. His Government has announced an urgent national drive to end rough sleeping, supported by an additional £340 million, while he has also promised a substantial increase in council housebuilding. That commitment deserves support. Nobody should have to…
(Bloomberg) — Two Sigma Investments’ billionaire co-founder John Overdeck schemed to leave his wife Laura “with as little as possible,” her lawyer said as the couple’s divorce trial began, an amount she pegged at $633 million. During opening statements Wednesday, Theresa Lyons, Laura’s lawyer, compared that figure to the more than $10 billion she said…
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks rose on Friday, putting the S & P 500 on pace for a record close thanks to a roughly 3.5% gain for the week. The…
October NY world sugar #11 (SBV26) is up +0.14 (+0.85%) today, and October London ICE white sugar #5 (SWV26) is up +2.50 (+0.49%). Sugar prices extended their week-long rally today, with NY sugar posting a 10-month nearest-futures high and London sugar posting a 15-month high. Concerns over lower global sugar production are propelling prices sharply…
Key Points Meta’s plan to build more efficient AI compute capacity could be significant for shareholders. Meta’s forward P/E multiple lags behind those of most of its “Magnificent Seven” peers. Wall Street remains skeptical about Meta’s capital spending plans, yet the company continues to report robust ad revenue growth. 10 stocks we like better than…